On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...